Differential signal transduction by five splice variants of the PACAP receptor

THE two forms of pituitary adenylyl cyclase-activating polypeptide (PACAP-27 and -38) are neuropeptides of the secretin/glucagon/ vasoactive intestinal polypeptide/growth-hormone-releasing hor-mone family and regulate hormone release from the pituitary and adrenal gland1–3. They may also be involved in spermatogenesis4, and PACAP-38 potently stimulates neuritogenesis and survival of cultured rat sympathetic neuroblast5,6 and promotes neurite out-growth of PC-12 cells7. The PACAP type-I receptor (found in hypothalamus, brain stem, pituitary, adrenal gland and testes), specific for PACAP, is positively coupled to adenylyl cyclase and phospholipase C. The recently cloned type II receptor does not discriminate between PACAP and vasoactive intestinal polypeptide and is coupled to only adenylyl cyclase8. Here we have used a new expression cloning strategy, based on the induction of a reporter gene by cyclic AMP, to isolate a complementary DNA encoding the type-I PACAP receptor. On transfection of this cDNA, both PACAP-27 and -38 stimulate adenylyl cyclase with similar EC50 values (50% effective concentration, 0.1–0.4 nM), whereas only PACAP-38 stimulates phospholipase C with high potency (EC50 = 15 nM). Four other splice variants were isolated with insertions at the C-terminal end of the third intracellular loop. Expression of these cDNAs revealed altered patterns of adenylyl cyclase and phospholipase C stimulation, suggesting a novel mechanism for fine tuning of signal transduction.

[1]  Stephen M. Mount,et al.  A catalogue of splice junction sequences. , 1982, Nucleic acids research.

[2]  J. Lechleiter,et al.  Distinct sequence elements control the specificity of G protein activation by muscarinic acetylcholine receptor subtypes. , 1990, The EMBO journal.

[3]  J. Lechleiter,et al.  Subcellular patterns of calcium release determined by G protein-specific residues of muscarinic receptors , 1991, Nature.

[4]  P. Robberecht,et al.  Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord , 1991, Regulatory Peptides.

[5]  A. Shenker,et al.  Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. , 1992, The Journal of biological chemistry.

[6]  I. Tatsuno,et al.  Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide. , 1990, Endocrinology.

[7]  I. Tatsuno,et al.  Hypothalamic binding sites for pituitary adenylate cyclase activating polypeptide: characterization and molecular identification 1 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  M. Culler,et al.  Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. , 1989, Biochemical and biophysical research communications.

[9]  R. Shigemoto,et al.  Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide , 1992, Neuron.

[10]  S. Nakanishi,et al.  A family of metabotropic glutamate receptors , 1992, Neuron.

[11]  M. Rosenfeld,et al.  Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth , 1992, Nature.

[12]  C. Fraser,et al.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. , 1992, The Biochemical journal.

[13]  M. Kozak.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. , 1987, Nucleic acids research.

[14]  Y. Sun,et al.  The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. , 1992, The Journal of biological chemistry.

[15]  F J Grant,et al.  Expression cloning and signaling properties of the rat glucagon receptor. , 1993, Science.

[16]  C. Gerfen,et al.  Multiple D2 dopamine receptors produced by alternative RNA splicing , 1989, Nature.

[17]  B. Koch,et al.  Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates cyclic AMP formation as well as peptide output of cultured pituitary melanotrophs and AtT-20 corticotrophs , 1992, Regulatory Peptides.

[18]  G. Wong,et al.  Molecular cloning and expression of a receptor for human tumor necrosis factor , 1990, Cell.

[19]  Y. Kaziro,et al.  Molecular cloning and expression of a cDNA encoding the secretin receptor. , 1991, The EMBO journal.

[20]  E. Dicicco-Bloom,et al.  Pituitary adenylate cyclase activating polypeptide (PACAP) potently stimulates mitosis, neuritogenesis and survival in cultured rat sympathetic neuroblasts , 1992, Regulatory Peptides.

[21]  J. Palacios,et al.  Visualization of a dopamine D1 receptor mRNA in human and rat brain. , 1991, Brain research. Molecular brain research.

[22]  M. Martres,et al.  Alternative splicing directs the expression of two D2 dopamine receptor isoforms , 1989, Nature.

[23]  C. Londos,et al.  A highly sensitive adenylate cyclase assay. , 1974, Analytical biochemistry.

[24]  B. Sommer,et al.  The dopamine D2 receptor: two molecular forms generated by alternative splicing. , 1989, The EMBO journal.

[25]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[26]  I. Black,et al.  Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts , 1990, Nature.

[27]  S. Heinemann,et al.  Alternative splicing generates metabotropic glutamate receptors inducing different patterns of calcium release in Xenopus oocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.